 Notwithstanding the lower limit of 90 mgdL equivalent to 5.0 mmolL, subjects with higher fasting plasma glucose will be prioritized, and efforts will be made to include subjects with fasting plasma glucose 100 mgdL equivalent to 5.6 mmolL in both cohorts. 